Refine
Year of publication
Document Type
- Article (104)
- Preprint (37)
- Conference Proceeding (4)
Has Fulltext
- yes (145)
Is part of the Bibliography
- no (145)
Keywords
- LHC (7)
- ALICE (3)
- ALICE experiment (3)
- Hadron-Hadron Scattering (3)
- Knowledge (3)
- Malaria (3)
- breast cancer (3)
- pp collisions (3)
- Attitude (2)
- Beauty production (2)
- Clinical Trials and Observations (2)
- Dengue (2)
- Diagnostik (2)
- Früherkennung (2)
- Mammakarzinom (2)
- Mountain (2)
- Nachsorge (2)
- Richtlinie (2)
- Single electrons (2)
- Zika virus (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- screening (2)
- 900 GeV (1)
- Aedes aegypti (1)
- Aedes albopictus (1)
- Aging (1)
- Akaike information criterion (AIC) (1)
- Anti-seizure medication (1)
- Antirheumatic agents (1)
- Asian bush mosquito (1)
- Awareness (1)
- BCOR (1)
- BCORL1 (1)
- Behavior (1)
- Bestandsstruktur (1)
- Biocatalysis (1)
- Biological invasion (1)
- Breast cancer (1)
- CVID (1)
- Care home (1)
- Central Europe (1)
- Charm physics (1)
- Chikungunya (1)
- Chikungunya virus (1)
- Child (1)
- Child abuse (1)
- Chorion (1)
- Cognitive behavioural therapy (1)
- Cognitive impairment (1)
- Cold hardiness (1)
- Cold tolerance (1)
- Community health services (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Computer hardware (1)
- Computer software (1)
- Computerlinguistik (1)
- Computers (1)
- Consensus (1)
- Dengue fever (1)
- Dengue virus (1)
- Depression (1)
- Dermatomyositis (1)
- Diagnosis (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Distance to water (1)
- Distribution limits (1)
- EP300 (1)
- EWSR1 (1)
- Elevation (1)
- Enzyme mechanisms (1)
- Epilepsy (1)
- European Society for Immunodeficiencies (ESID) (1)
- European registry for idiopathic pulmonary fibrosis (eurIPFreg) (1)
- Everolimus (1)
- FOXO1 (1)
- Femtoscopy (1)
- Filariasis (1)
- Gene fusion (1)
- General practitioner (1)
- Generation time (1)
- Generic NLP Architecture (1)
- Geographically weighted regression (GWR) (1)
- German PID-NET registry (1)
- Global positioning system (1)
- HBT (1)
- HPSG Parsing (1)
- Habitattradition (1)
- Hadron production (1)
- Healthcare worker (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hepatitis B (1)
- Hepatitis B infection (1)
- Hepatitis B vaccination (1)
- High altitude (1)
- Himalayas (1)
- Hindu Kush Himalayas (1)
- Hygroscopicity (1)
- IE (1)
- Idiopathic pulmonary fibrosis (IPF) (1)
- IgG substitution therapy (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Internet (1)
- Interspecific competition (1)
- Interstitial lung diseases (ILD) (1)
- Jets (1)
- KAP (1)
- KCGS (1)
- Leishmaniasis (1)
- Livestock (1)
- Local climate (1)
- Lymphoid Neoplasia (1)
- Magnetic resonance imaging (1)
- Malaria prevalence (1)
- Mental health and psychiatry (1)
- Microalgae (1)
- Mid-rapidity (1)
- Migration (1)
- Mitteleuropa (1)
- Mosquito (1)
- Multi-strange baryons (1)
- Multivariable analysis (1)
- Myeloid Neoplasia (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NPH insulin (1)
- Neuroepithelial tumor (1)
- Niche differentiation (1)
- Nuclear modification factor (1)
- Older adult (1)
- Oncology (1)
- Ordinary least squares (OLS) (1)
- Organosulfates (1)
- Overwintering (1)
- PID prevalence (1)
- PLAGL1 (1)
- PYTHIA (1)
- Parkinson disease (1)
- Pb–Pb (1)
- Phenotypic plasticity (1)
- Physical environment (1)
- Population-based screening (1)
- Post-traumatic stress disorder (1)
- Poverty (1)
- Practice (1)
- Proton–proton (1)
- Prototypes (1)
- Psychological and psychosocial issues (1)
- Quality of life (1)
- Rainfall (1)
- Rearing temperature (1)
- Recall rate (1)
- Relativistic heavy ion physics (1)
- Resource competition (1)
- Rhabdomyoma (1)
- Rural area (1)
- SOA (1)
- Sandfly (1)
- Seizure (1)
- Shallow NLP (1)
- Single muons (1)
- Social epidemiology (1)
- Social health determinants (1)
- Stigma (1)
- Sub-zero exposure (1)
- Sumatra (1)
- Supratentorial (1)
- Totholzangebot (1)
- Transportation (1)
- Transverse momentum (1)
- Urwaldreliktarten (1)
- Vector mosquito (1)
- Water chemistry (1)
- Winter survival (1)
- X-ray crystallography (1)
- XML (1)
- Zika (1)
- Zika vaccine (1)
- Zoopotentation (1)
- Zooprophylaxis (1)
- acute myeloid leukemia (1)
- antibodies (1)
- b-cell lymphomas (1)
- basal insulin (1)
- bendamustine (1)
- brain metastases (1)
- cancer (1)
- chemogenomic set (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- cold tolerance (1)
- compaction (1)
- dead wood (1)
- drug discovery (1)
- druggable genome (1)
- epidemics (1)
- feeding (1)
- forest structure (1)
- freeze avoidance (1)
- habitat tradition (1)
- hematopoietic stem cell transplantation (1)
- hypoglycaemia (1)
- kinase inhibitor (1)
- leukapheresis (1)
- life cycle (1)
- loss-of-function (1)
- lymphoma (1)
- mTOR inhibitor (1)
- metformin (1)
- monsoon (1)
- pancreatic cancer (1)
- pattern (1)
- phenotypic screening (1)
- postmonsoon (1)
- primary immunodeficiency (PID) (1)
- primeval forest (1)
- protein kinase (1)
- public health (1)
- radiological (1)
- registry for primary immunodeficiency (1)
- reserve substance (1)
- risk stratification (1)
- rituximab (1)
- small molecules (1)
- spectra (1)
- survival (1)
- understudied kinase (1)
- vaccine acceptance (1)
- vaccine trial (1)
- water parameter (1)
- wax layer (1)
- willingness to participate (1)
- winter survival (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (84)
- Frankfurt Institute for Advanced Studies (FIAS) (68)
- Informatik (68)
- Medizin (44)
- Geowissenschaften (11)
- Institut für Ökologie, Evolution und Diversität (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Senckenbergische Naturforschende Gesellschaft (3)
- MPI für Biophysik (2)
- Biochemie und Chemie (1)
Ziele: Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) publiziert und koordiniert wurde, ist es, die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms zu optimieren.
Methoden: Der Aktualisierungsprozess der S3-Leitlinie aus 2012 basierte zum einen auf der Adaptation identifizierter Quellleitlinien und zum anderen auf Evidenzübersichten, die nach Entwicklung von PICO-(Patients/Interventions/Control/Outcome-)Fragen, systematischer Recherche in Literaturdatenbanken sowie Selektion und Bewertung der gefundenen Literatur angefertigt wurden. In den interdisziplinären Arbeitsgruppen wurden auf dieser Grundlage Vorschläge für Empfehlungen und Statements erarbeitet, die im Rahmen von strukturierten Konsensusverfahren modifiziert und graduiert wurden.
Empfehlungen: Der Teil 1 dieser Kurzversion der Leitlinie zeigt Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms: Der Stellenwert des Mammografie-Screenings wird in der aktualisierten Leitlinienversion bestätigt und bildet damit die Grundlage der Früherkennung. Neben den konventionellen Methoden der Karzinomdiagnostik wird die Computertomografie (CT) zum Staging bei höherem Rückfallrisiko empfohlen. Die Nachsorgekonzepte beinhalten Untersuchungsintervalle für die körperliche Untersuchung, Ultraschall und Mammografie, während weiterführende Gerätediagnostik und Tumormarkerbestimmungen bei der metastasierten Erkrankung Anwendung finden.
Purpose: The aim of this official guideline coordinated and published by the German Society for Gynecology and Obstetrics (DGGG) and the German Cancer Society (DKG) was to optimize the screening, diagnosis, therapy and follow-up care of breast cancer.
Methods: The process of updating the S3 guideline dating from 2012 was based on the adaptation of identified source guidelines which were combined with reviews of evidence compiled using PICO (Patients/Interventions/Control/Outcome) questions and the results of a systematic search of literature databases and the selection and evaluation of the identified literature. The interdisciplinary working groups took the identified materials as their starting point to develop recommendations and statements which were modified and graded in a structured consensus procedure.
Recommendations: Part 1 of this short version of the guideline presents recommendations for the screening, diagnosis and follow-up care of breast cancer. The importance of mammography for screening is confirmed in this updated version of the guideline and forms the basis for all screening. In addition to the conventional methods used to diagnose breast cancer, computed tomography (CT) is recommended for staging in women with a higher risk of recurrence. The follow-up concept includes suggested intervals between physical, ultrasound and mammography examinations, additional high-tech diagnostic procedures, and the determination of tumor markers for the evaluation of metastatic disease.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
A measurement of the transverse momentum spectra of jets in Pb-Pb collisions at sNN−−−√=2.76 TeV is reported. Jets are reconstructed from charged particles using the anti-kT jet algorithm with jet resolution parameters R of 0.2 and 0.3 in pseudo-rapidity |η|<0.5. The transverse momentum pT of charged particles is measured down to 0.15 GeV/c which gives access to the low pT fragments of the jet. Jets found in heavy-ion collisions are corrected event-by-event for average background density and on an inclusive basis (via unfolding) for residual background fluctuations and detector effects. A strong suppression of jet production in central events with respect to peripheral events is observed. The suppression is found to be similar to the suppression of charged hadrons, which suggests that substantial energy is radiated at angles larger than the jet resolution parameter R=0.3 considered in the analysis. The fragmentation bias introduced by selecting jets with a high pT leading particle, which rejects jets with a soft fragmentation pattern, has a similar effect on the jet yield for central and peripheral events. The ratio of jet spectra with R=0.2 and R=0.3 is found to be similar in Pb-Pb and simulated PYTHIA pp events, indicating no strong broadening of the radial jet structure in the reconstructed jets with R<0.3.
The pT-differential inclusive production cross section of the prompt charm-strange meson Ds+ in the rapidity range |y|<0.5 was measured in proton–proton collisions at s=7 TeV at the LHC using the ALICE detector. The analysis was performed on a data sample of 2.98×108 events collected with a minimum-bias trigger. The corresponding integrated luminosity is Lint=4.8 nb−1. Reconstructing the decay Ds+→ϕπ+, with ϕ→K−K+, and its charge conjugate, about 480 Ds± mesons were counted, after selection cuts, in the transverse momentum range 2<pT<12 GeV/c. The results are compared with predictions from models based on perturbative QCD. The ratios of the cross sections of four D meson species (namely D0, D+, D⁎+ and Ds+) were determined both as a function of pT and integrated over pT after extrapolating to full pT range, together with the strangeness suppression factor in charm fragmentation. The obtained values are found to be compatible within uncertainties with those measured by other experiments in e+e−, ep and pp interactions at various centre-of-mass energies.
he first measurements of the invariant differential cross sections of inclusive π0 and η meson production at mid-rapidity in proton–proton collisions at s=0.9 TeV and s=7 TeV are reported. The π0 measurement covers the ranges 0.4<pT<7 GeV/c and 0.3<pT<25 GeV/c for these two energies, respectively. The production of η mesons was measured at s=√7 TeV in the range 0.4<pT<15 GeV/c. Next-to-Leading Order perturbative QCD calculations, which are consistent with the π0 spectrum at s=0.9 TeV, overestimate those of π0 and η mesons at s=√7 TeV, but agree with the measured η/π0 ratio at s=√7 TeV.
The ALICE Collaboration has measured inclusive J/ψ production in pp collisions at a center-of-mass energy √s=2.76 TeV at the LHC. The results presented in this Letter refer to the rapidity ranges |y|<0.9 and 2.5<y<4 and have been obtained by measuring the electron and muon pair decay channels, respectively. The integrated luminosities for the two channels are Linte=1.1 nb−1 and Lintμ=19.9 nb−1, and the corresponding signal statistics are NJ/ψe+e−=59±14 and NJ/ψμ+μ−=1364±53. We present dσJ/ψ/dy for the two rapidity regions under study and, for the forward-y range, d2σJ/ψ/dydpt in the transverse momentum domain 0<pt<8 GeV/c. The results are compared with previously published results at s=7 TeV and with theoretical calculations.
The ALICE experiment has measured low-mass dimuon production in pp collisions at √s=7 TeV in the dimuon rapidity region 2.5<y<4. The observed dimuon mass spectrum is described as a superposition of resonance decays (η,ρ,ω,η′,ϕ) into muons and semi-leptonic decays of charmed mesons. The measured production cross sections for ω and ϕ are σω(1<pt<5 GeV/c,2.5<y<4)=5.28±0.54(stat)±0.49(syst) mb and σϕ(1<pt<5 GeV/c,2.5<y<4)=0.940±0.084(stat)±0.076(syst) mb. The differential cross sections d2σ/dydpt are extracted as a function of pt for ω and ϕ. The ratio between the ρ and ω cross section is obtained. Results for the ϕ are compared with other measurements at the same energy and with predictions by models.
Identical neutral kaon pair correlations are measured in √s=7 TeV pp collisions in the ALICE experiment. One-dimensional Ks0Ks0 correlation functions in terms of the invariant momentum difference of kaon pairs are formed in two multiplicity and two transverse momentum ranges. The femtoscopic parameters for the radius and correlation strength of the kaon source are extracted. The fit includes quantum statistics and final-state interactions of the a0/f0 resonance. Ks0Ks0 correlations show an increase in radius for increasing multiplicity and a slight decrease in radius for increasing transverse mass, mT, as seen in ππ correlations in pp collisions and in heavy-ion collisions. Transverse mass scaling is observed between the Ks0Ks0 and ππ radii. Also, the first observation is made of the decay of the f2′(1525) meson into the Ks0Ks0 channel in pp collisions.
The elliptic, v2, triangular, v3, and quadrangular, v4, azimuthal anisotropic flow coefficients are measured for unidentified charged particles, pions, and (anti-)protons in Pb–Pb collisions at √sNN=2.76 TeV with the ALICE detector at the Large Hadron Collider. Results obtained with the event plane and four-particle cumulant methods are reported for the pseudo-rapidity range |η|<0.8 at different collision centralities and as a function of transverse momentum, pT, out to pT=20 GeV/c. The observed non-zero elliptic and triangular flow depends only weakly on transverse momentum for pT>8 GeV/c. The small pT dependence of the difference between elliptic flow results obtained from the event plane and four-particle cumulant methods suggests a common origin of flow fluctuations up to pT=8 GeV/c. The magnitude of the (anti-)proton elliptic and triangular flow is larger than that of pions out to at least pT=8 GeV/c indicating that the particle type dependence persists out to high pT.